Full-Time

Senior – Medical Science Liaison

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

$120k - $190kAnnually

+ Incentive Compensation + Restricted Stock Units

Senior

Company Historically Provides H1B Sponsorship

Remote in USA

Candidates must reside in NY, NJ, or PA.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Public Speaking

You match the following Tempus's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Fundamental understanding of the field of molecular oncology, comprehensive genomic profiling, and related patient management algorithms in early and advanced-stage cancer, with the ability to interpret clinical trial data.
  • Existing KOL relationships in the field of oncology;
  • Working knowledge of genomic laboratory-developed testing (LDT); familiarity with CLIA-88’, CAP, Sunshine Act (2013);
  • Proficient public speaking skills with an ability to effectively communicate clinical data and complex scientific concepts;
  • Exceptional interpersonal communication skills, strong inter-, and intradepartmental management skills, ability to educate and train;
  • Self-starter, who can work autonomously to deliver on tight timelines;
  • Ability to travel (up to 50%);
  • Advanced scientific or medical degree (PhD, PharmD, MD, MSN, BSN)
  • Basic understanding of oncology required; basic understanding of molecular testing is strongly preferred.
Responsibilities
  • Support commercial team efforts promoting exchange of clinical/scientific/technical information with regional KOLs, community physicians, medical directors, and other HCPs in the field of oncology, including delivering educational presentations, facilitating speaker engagements (live or virtual), and discussions for clinical research.
  • Provide first-class service in clinical science as part of Tempus medical support program to physicians for rapid response to patient NGS test result questions and review of scientific data.
  • Support virtual tumor board presentations to multidisciplinary healthcare provider teams to discuss interesting patient cases explaining guideline-recommended treatment options.
  • Provide scientific education for internal stakeholders in collaboration with Learning & Development team.
  • Attend conferences and other key meetings to facilitate KOL meetings and provide comprehensive meeting synopses and summaries of high-impact abstracts/posters/oral presentations.
  • Continuously update internal stakeholders on relevant medical and scientific knowledge as well as proactively sharing market intelligence.
Desired Qualifications
  • 1+ years of MSL experience in diagnostics, biotech, or pharmaceutical industries.

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data to assist physicians in making informed treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights, aiming to improve patient care and support drug development.

Company Stage

IPO

Total Funding

$894.9M

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • AI integration in EHR systems supports Tempus' data analytics capabilities.
  • Growing demand for personalized medicine boosts Tempus' therapy solutions.
  • AI-powered health apps market growth supports Tempus' olivia app success.

What critics are saying

  • Ambry Genetics acquisition may strain Tempus' financial resources and integration efforts.
  • xT CDx test faces competition, impacting market penetration and revenue.
  • olivia app may raise privacy concerns, affecting user adoption and trust.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform offers personalized therapy options, enhancing patient care and drug development.
  • Tempus' pan-cancer organoid platform and liquid biopsy assay are unique in cancer research.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Relocation Assistance

Company Equity

Performance Bonus